Expertise in
9
conditions

Dr. Svetislava Vukelja

Hematology
Texas Oncology P.A.
910 E Houston St Ste 100, 
Tyler, TX 
Expertise in
9
conditions
Texas Oncology P.A.
910 E Houston St Ste 100, 
Tyler, TX 

Overview

Svetislava Vukelja is a Hematologist in Tyler, Texas. Dr. Vukelja is highly rated in 9 conditions, according to our data. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Pancreatic Cancer, and Familial Pancreatic Cancer.

Her clinical research consists of co-authoring 11 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Hematology

Licenses

Internal Medicine in TX

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Friday Health

Accepted plan types not found. Please verify directly with the provider.

Oscar
  • EPO
  • HMO
  • PPO

Locations

Texas Oncology P.A.
910 E Houston St Ste 100, Tyler, TX 75702

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

MONARCH 2: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Fulvestrant With or Without Abemaciclib, a CDK4/6 Inhibitor, for Women With Hormone Receptor Positive, HER2 Negative Locally Advanced or Metastatic Breast Cancer
MONARCH 2: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Fulvestrant With or Without Abemaciclib, a CDK4/6 Inhibitor, for Women With Hormone Receptor Positive, HER2 Negative Locally Advanced or Metastatic Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: October 21, 2025
Intervention Type: Drug
Study Drugs: Abemaciclib, Fulvestrant
Study Phase: Phase 3
A Phase II, Multicenter, Randomized, Open-label Study to Evaluate the Safety and Efficacy of 400 mg of Ribociclib in Combination With Non-steroidal Aromatase Inhibitors for the Treatment of Pre- and Postmenopausal Women With Hormone Receptor-positive, HER2-negative Advanced Breast Cancer Who Received no Prior Therapy for Advanced Disease
A Phase II, Multicenter, Randomized, Open-label Study to Evaluate the Safety and Efficacy of 400 mg of Ribociclib in Combination With Non-steroidal Aromatase Inhibitors for the Treatment of Pre- and Postmenopausal Women With Hormone Receptor-positive, HER2-negative Advanced Breast Cancer Who Received no Prior Therapy for Advanced Disease
Enrollment Status: Completed
Publish Date: October 16, 2025
Intervention Type: Drug
Study Drugs: Ribociclib, Letrozole or Anastrozole, Goserelin
Study Phase: Phase 2
A Phase III Randomized Double-blind, Placebo Controlled Study of Alpelisib in Combination With Fulvestrant for Men and Postmenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer Which Progressed on or After Aromatase Inhibitor Treatment
A Phase III Randomized Double-blind, Placebo Controlled Study of Alpelisib in Combination With Fulvestrant for Men and Postmenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer Which Progressed on or After Aromatase Inhibitor Treatment
Enrollment Status: Completed
Publish Date: February 13, 2025
Intervention Type: Drug
Study Drugs: Fulvestrant, Alpelisib
Study Phase: Phase 3
View 2 Less Clinical Trials

11 Total Publications

Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology]).
Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology]).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 09, 2024
Similar Doctors
Expertise in
46
conditions
Dr. Arielle Lee
Hematology
Expertise in
46
conditions
Dr. Arielle Lee
Hematology

Tyler Texas Radiation Oncology PA

721 Clinic Dr # A, 
Tyler, TX 
 (1.7 miles away)
903-592-6152
Languages Spoken:
English
See accepted insurances

Arielle Lee is a Hematologist in Tyler, Texas. Dr. Lee is highly rated in 46 conditions, according to our data. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Familial Colorectal Cancer, Colorectal Cancer, and Bone Marrow Aspiration.

Expertise in
49
conditions
Dr. Robert Droder
Hematology
Expertise in
49
conditions
Dr. Robert Droder
Hematology

UT Health East Texas Hope Cancer Center

721 Clinic Dr # A, 
Tyler, TX 
 (1.7 miles away)
903-592-6152
Languages Spoken:
English
See accepted insurances

Robert Droder is a Hematologist in Tyler, Texas. Dr. Droder is highly rated in 49 conditions, according to our data. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Familial Colorectal Cancer, Childhood Iron Deficiency Anemia, and Bone Marrow Aspiration.

Expertise in
48
conditions
Dr. Marc Usrey
Hematology
Expertise in
48
conditions
Dr. Marc Usrey
Hematology

UT Health East Texas Hope Cancer Center

721 Clinic Dr # A, 
Tyler, TX 
 (1.7 miles away)
903-592-6152
Languages Spoken:
English
See accepted insurances

Marc Usrey is a Hematologist in Tyler, Texas. Dr. Usrey is highly rated in 48 conditions, according to our data. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Cutaneous T-Cell Lymphoma (CTCL), Childhood Iron Deficiency Anemia, and Bone Marrow Aspiration.

Frequently Asked Questions about Dr. Svetislava Vukelja

How do I make an appointment with Dr. Svetislava Vukelja?

You can book an appointment with Dr. Svetislava Vukelja by calling their office at 903-579-9800. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Svetislava Vukelja a top-rated expert for Breast Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Svetislava Vukelja is classified as an Distinguished expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Svetislava Vukelja specialize in?

While Dr. Svetislava Vukelja is a Hematology, they have specific expertise in Breast Cancer, Paget Disease of the Breast, and Pancreatic Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Svetislava Vukelja participate in research or clinical trials?

Yes. Dr. Svetislava Vukelja has published 11 articles and abstracts on conditions like Breast Cancer. You can view a list of Dr. Svetislava Vukelja's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Svetislava Vukelja accept my insurance?

Dr. Svetislava Vukelja accepts most major insurance plans, including Friday Health and Oscar. We recommend calling the office directly at 903-579-9800 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Vukelja's expertise for a condition
ConditionClose
    View All 43 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile